New Recombinant Human anti-SARS-CoV-2 Antibody is released
New Recombinant Human anti-SARS-CoV-2 Antibody is released
The nucleocapsid protein is the most abundant protein in coronavirus and is often used as a marker in diagnostic assays. arigo is proud to introduce the newly released recombinant human anti-SARS-CoV-2 nucleocapsid protein antibody (ARG66735) and SARS-CoV-2 recombinant proteins. The antibody and proteins are ideal for understanding the molecular mechanism of viral infection and pathogenesis. Moreover, that is the best solution for validation testing of newly developed diagnostic reagents or therapeutic strategies for COVID-19. |
SARS-CoV-2 nucleocapsid Human IgG1
|
Goat anti-Human IgG antibody (HRP), pre-adsorbed (ARG23887) |
SARS-CoV-2 recombinant proteins |
SARS-CoV-2 nucleocapsid E. coli expressed |
His-SUMO tagged SARS-CoV-2 HEK293 expressed |
His-tagged SARS-CoV-2 Spike E. coli expressed |
His-tagged SARS-CoV-2 Spike E. coli expressed |
Antibodies cross-react with SARS-CoV-2 |
SARS-CoV Spike protein antibody [1A9] Mouse IgG1 |
SARS-CoV ORF7a antibody [3C9] Mouse IgG1 |
Antibodies against SARS-CoV |
SARS-CoV Spike protein Rabbit IgG |
SARS-CoV Spike protein Rabbit IgG |
SARS-CoV M protein Rabbit IgG
|
SARS-CoV nucleocapsid Mouse IgG1 |
SARS-CoV NSP8 Mouse IgG2a |
SARS-CoV RdRp R2 Mouse IgG1
|
Antibodies for studying viral infection |
Reactivity: Hu, Ms, Rat |
Reactivity: Hu |
Reactivity: Hu, Ms, Rat |
Reactivity: Hu, Ms |
Reactivity: Hu |
Reactivity: Hu
|
Related article |